{"id":"https://openalex.org/W2053565710","doi":"https://doi.org/10.1039/c1md00077b","title":"HIV-1 protease inhibitors with a tertiary alcohol containing transition-state mimic and various P2 and P1\u2032 substituents","display_name":"HIV-1 protease inhibitors with a tertiary alcohol containing transition-state mimic and various P2 and P1\u2032 substituents","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2053565710","doi":"https://doi.org/10.1039/c1md00077b","mag":"2053565710"},"language":"en","primary_location":{"id":"doi:10.1039/c1md00077b","doi":"https://doi.org/10.1039/c1md00077b","is_oa":false,"landing_page_url":"https://doi.org/10.1039/c1md00077b","pdf_url":null,"source":{"id":"https://openalex.org/S191926780","display_name":"MedChemComm","issn_l":"2040-2503","issn":["2040-2503","2040-2511"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","norway-1","poland-70"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedChemComm","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058891726","display_name":"Per \u00d6hrngren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Per \u00d6hrngren","raw_affiliation_strings":["Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040529930","display_name":"Xiongyu Wu","orcid":"https://orcid.org/0000-0001-6756-2276","observed_orcids":["https://orcid.org/0000-0001-6756-2276"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Xiongyu Wu","raw_affiliation_strings":["Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Magnus Persson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Magnus Persson","raw_affiliation_strings":["Department of Cell and Molecular Biology, Structural Biology, BMC, Uppsala University, Box 596, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell and Molecular Biology, Structural Biology, BMC, Uppsala University, Box 596, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075202881","display_name":"Jenny K. Ekegren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jenny K. Ekegren","raw_affiliation_strings":["Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072640010","display_name":"Hans Wallberg","orcid":"https://orcid.org/0009-0000-8550-6366","observed_orcids":["https://orcid.org/0009-0000-8550-6366"]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Hans Wallberg","raw_affiliation_strings":["Medivir AB, PO Box 1086, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086480661","display_name":"Lotta Vrang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lotta Vrang","raw_affiliation_strings":["Medivir AB, PO Box 1086, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002491926","display_name":"\u00c5sa Rosenquist","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"\u00c5sa Rosenquist","raw_affiliation_strings":["Medivir AB, PO Box 1086, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112790292","display_name":"Bertil Samuelsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088043","display_name":"Medivir (Sweden)","ror":"https://ror.org/002jks503","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210088043"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bertil Samuelsson","raw_affiliation_strings":["Medivir AB, PO Box 1086, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medivir AB, PO Box 1086, Huddinge, Sweden","institution_ids":["https://openalex.org/I4210088043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089105174","display_name":"Torsten Unge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Torsten Unge","raw_affiliation_strings":["Department of Cell and Molecular Biology, Structural Biology, BMC, Uppsala University, Box 596, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cell and Molecular Biology, Structural Biology, BMC, Uppsala University, Box 596, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5008347976","display_name":"Mats Larhed","orcid":"https://orcid.org/0000-0001-6258-0635","observed_orcids":["https://orcid.org/0000-0001-6258-0635"]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Mats Larhed","raw_affiliation_strings":["Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Organic Pharmaceutical Chemistry, BMC, Uppsala University, Box 574, Uppsala, Sweden","institution_ids":["https://openalex.org/I123387679"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5008347976"],"corresponding_institution_ids":["https://openalex.org/I123387679"],"apc_list":null,"apc_paid":null,"fwci":1.3214,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.78291168,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"2","issue":"8","first_page":"701","last_page":"701"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.019899999722838402,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.010300000198185444,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-protease-inhibitors","display_name":"HIV-1 protease inhibitors","score":1.0},{"id":"https://openalex.org/keywords/tert-leucine","display_name":"tert-leucine","score":0.7170000076293945},{"id":"https://openalex.org/keywords/atazanavir","display_name":"atazanavir","score":0.7099999785423279},{"id":"https://openalex.org/keywords/x-ray-crystallography","display_name":"X-ray crystallography","score":0.6970000267028809},{"id":"https://openalex.org/keywords/drug-permeability","display_name":"drug permeability","score":0.5230000019073486},{"id":"https://openalex.org/keywords/drug-stability","display_name":"drug stability","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2778439535","wikidata":"https://www.wikidata.org/wiki/Q188777","display_name":"Amide","level":2,"score":0.8221853971481323},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7508617043495178},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.6440922021865845},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.6252090334892273},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6241405010223389},{"id":"https://openalex.org/C2777583353","wikidata":"https://www.wikidata.org/wiki/Q410261","display_name":"HIV-1 protease","level":4,"score":0.4944884777069092},{"id":"https://openalex.org/C204921945","wikidata":"https://www.wikidata.org/wiki/Q899689","display_name":"Side chain","level":3,"score":0.48740676045417786},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.46758556365966797},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.46750032901763916},{"id":"https://openalex.org/C2781066024","wikidata":"https://www.wikidata.org/wiki/Q156","display_name":"Alcohol","level":2,"score":0.41107094287872314},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1823713183403015},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14292219281196594},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1039/c1md00077b","doi":"https://doi.org/10.1039/c1md00077b","is_oa":false,"landing_page_url":"https://doi.org/10.1039/c1md00077b","pdf_url":null,"source":{"id":"https://openalex.org/S191926780","display_name":"MedChemComm","issn_l":"2040-2503","issn":["2040-2503","2040-2511"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","norway-1","poland-70"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MedChemComm","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320940","display_name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","ror":"https://ror.org/044wr7g58"},{"id":"https://openalex.org/F4320322581","display_name":"Vetenskapsr\u00e5det","ror":"https://ror.org/03zttf063"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W126493026","https://openalex.org/W1964792825","https://openalex.org/W1966952032","https://openalex.org/W1968359293","https://openalex.org/W1976730142","https://openalex.org/W1977648979","https://openalex.org/W1978890358","https://openalex.org/W1981669483","https://openalex.org/W1985469117","https://openalex.org/W1990592406","https://openalex.org/W1991243909","https://openalex.org/W1991380804","https://openalex.org/W1992850824","https://openalex.org/W1995396220","https://openalex.org/W2016041703","https://openalex.org/W2016371679","https://openalex.org/W2019261111","https://openalex.org/W2024536147","https://openalex.org/W2031991206","https://openalex.org/W2035095394","https://openalex.org/W2041092566","https://openalex.org/W2044571535","https://openalex.org/W2054525948","https://openalex.org/W2071395304","https://openalex.org/W2072152260","https://openalex.org/W2077472737","https://openalex.org/W2080237955","https://openalex.org/W2082529161","https://openalex.org/W2089127100","https://openalex.org/W2089382521","https://openalex.org/W2094276022","https://openalex.org/W2096099963","https://openalex.org/W2102646147","https://openalex.org/W2104270610","https://openalex.org/W2107165605","https://openalex.org/W2107988978","https://openalex.org/W2123166384","https://openalex.org/W2127137755","https://openalex.org/W2128708905","https://openalex.org/W2131046434","https://openalex.org/W2140534639","https://openalex.org/W2140900471","https://openalex.org/W2162196815","https://openalex.org/W2167199452","https://openalex.org/W2170958236","https://openalex.org/W2464955112","https://openalex.org/W2951869381"],"related_works":["https://openalex.org/W2082529161","https://openalex.org/W2094276022","https://openalex.org/W2167199452","https://openalex.org/W2041092566","https://openalex.org/W2073251219","https://openalex.org/W334846575","https://openalex.org/W2063511171","https://openalex.org/W2767487215","https://openalex.org/W2613177877","https://openalex.org/W2038314839"],"abstract_inverted_index":{"Two":[0],"series,":[1],"including":[2],"in":[3,80,158,165,177],"total":[4],"18":[5],"novel":[6,121],"HIV-1":[7],"protease":[8,186],"inhibitors,":[9],"comprising":[10],"a":[11,112,130,147,170],"tertiary":[12],"alcohol":[13],"as":[14,84],"the":[15,25,68,81,139,159,166,175,182,185],"transition-state":[16],"mimic":[17],"have":[18],"been":[19],"synthesised":[20],"and":[21,47,51,64,75,96,111],"evaluated.":[22],"Replacement":[23],"of":[24,89,109,138,174,184],"previously":[26,113,131,140],"used,":[27],"but":[28],"metabolically":[29],"unstable,":[30],"indanol":[31,115,142],"amide":[32,116,143,164],"group":[33],"with":[34,44,71,123,135,146],"amino":[35],"acid":[36],"derived":[37,149],"aliphatic":[38],"P2\u2013P3":[39,150],"moieties":[40],"provided":[41],"potent":[42],"inhibitors":[43,70,122],"low":[45],"Ki-":[46],"EC50-values":[48],"(2.7":[49],"nM":[50],"2.0":[52],"\u03bcM,":[53],"respectively).":[54],"The":[55,102,120,162],"P1\u2032":[56,126],"subunit":[57],"was":[58],"varied":[59],"using":[60],"10":[61],"different":[62],"aromatic":[63],"heteroaromatic":[65],"substituents":[66],"furnishing":[67],"corresponding":[69],"retained":[72],"activity.":[73],"Permeability":[74],"stability":[76],"studies":[77],"showed":[78],"examples":[79],"same":[82],"range":[83],"Atazanavir.":[85],"X-Ray":[86],"crystallographic":[87],"analysis":[88],"two":[90],"selected":[91],"inhibitor":[92,118],"enzyme":[93],"co-complexes":[94],"(9a":[95],"9d)":[97],"supplied":[98],"detailed":[99],"structural":[100],"information.":[101],"binding":[103],"modes":[104],"were":[105],"compared":[106],"to":[107,179],"those":[108],"Atazanavir":[110],"reported":[114],"containing":[117],"(14).":[119],"an":[124],"elongated":[125],"side":[127,151],"chain":[128,156],"enabled":[129],"unexploited":[132],"edge-on":[133],"interaction":[134],"Phe53/153.":[136],"Exchange":[137],"used":[141],"P2":[144],"moiety,":[145],"tert-leucine":[148],"chain,":[152],"furnished":[153],"small":[154],"main":[155],"displacements":[157],"S2\u2013S3":[160],"pocket.":[161],"methyl":[163],"P3":[167],"position":[168],"caused":[169],"2":[171],"\u00c5":[172],"shift":[173],"Arg8/108":[176],"comparison":[178],"14,":[180],"indicating":[181],"flexibility":[183],"active":[187],"site.":[188]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}